Tomorrow Investor

Food & Health
pharma pipeline shift illustration
Pfizer's MDL Exit: Boosts Long-Term Pharma Pipeline
Pfizer (PFE) has been dismissed as a defendant in the sweeping multi-state generic drug price-fixing antitrust lawsuit, removing a material legal liability that had shadowed the company’s long-term earnings profile. For investors focused on pipeline durability and margin trajectory, the dismissal...
pharma pipeline shift illustration
Sanofi's MS Drug Gets EU Nod, Boosting Pharma Pipeline
Europe’s drug advisory committee recommended approval of Sanofi’s (SNY) Cenrifki for non-relapsing...
pharma pipeline shift illustration
AbbVie's $10.9B Move Redefines Autoimmune Focus
AbbVie (ABBV) is nearing a $10.9 billion all-cash deal for Apogee Therapeutics (APGE), acquiring a long-acting...
pharma pipeline shift illustration
GSK Blujepa: Transforming UTI Treatment Landscape
GSK plc (GSK.L / GSK) secured U.S. FDA approval for gepotidacin (Blujepa), a first-in-class oral antibiotic...
long-term revenue mix illustration
JBS Plant Closure: New Beef Market Challenges
JBS USA, the world’s largest meatpacker, will permanently close its Swift Beef Company facility...
pharma pipeline shift illustration
Pharma Shifts: GLP-1 Coverage Pullback
Cigna (CI) will drop coverage of GLP-1 obesity drugs Wegovy and Zepbound from its own employee health...
pharma pipeline shift illustration
Legend Biotech's CAR-T Data Sparks 40% Rally
Legend Biotech (LEGN) shares jumped roughly 40% on Tuesday after early Phase 1 data for its in vivo CAR-T...

Trending

long-term revenue mix illustration
U.S. EV Market Faces New Polestar Ban
Bumble sale illustration
Bumble Considers Sale Amid Plummeting Valuations
pharma pipeline shift illustration
Pfizer's MDL Exit: Boosts Long-Term Pharma Pipeline

CATEGORIES

SIGNUP TO OUR NEWSLETTER

Subscribe

Get breaking market insights directly to your inbox